MGRM vs. TMCI, DCTH, CLPT, NPCE, NYXH, SMLR, ZIMV, NNOX, TCMD, and LUNG
Should you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include Treace Medical Concepts (TMCI), Delcath Systems (DCTH), ClearPoint Neuro (CLPT), NeuroPace (NPCE), Nyxoah (NYXH), Semler Scientific (SMLR), ZimVie (ZIMV), Nano-X Imaging (NNOX), Tactile Systems Technology (TCMD), and Pulmonx (LUNG). These companies are all part of the "medical equipment" industry.
Monogram Orthopaedics vs.
Monogram Orthopaedics (NASDAQ:MGRM) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, community ranking, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.
0.4% of Monogram Orthopaedics shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 28.1% of Monogram Orthopaedics shares are held by company insiders. Comparatively, 24.4% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Treace Medical Concepts received 23 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users. However, 75.00% of users gave Monogram Orthopaedics an outperform vote while only 45.61% of users gave Treace Medical Concepts an outperform vote.
Monogram Orthopaedics currently has a consensus price target of $5.40, suggesting a potential upside of 82.43%. Treace Medical Concepts has a consensus price target of $10.14, suggesting a potential upside of 18.22%. Given Monogram Orthopaedics' stronger consensus rating and higher probable upside, equities research analysts clearly believe Monogram Orthopaedics is more favorable than Treace Medical Concepts.
Monogram Orthopaedics has higher earnings, but lower revenue than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Monogram Orthopaedics, indicating that it is currently the more affordable of the two stocks.
In the previous week, Treace Medical Concepts had 3 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 5 mentions for Treace Medical Concepts and 2 mentions for Monogram Orthopaedics. Treace Medical Concepts' average media sentiment score of 1.04 beat Monogram Orthopaedics' score of 0.86 indicating that Treace Medical Concepts is being referred to more favorably in the news media.
Monogram Orthopaedics has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -30.33%. Treace Medical Concepts' return on equity of -51.12% beat Monogram Orthopaedics' return on equity.
Monogram Orthopaedics has a beta of 1.66, suggesting that its stock price is 66% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500.
Summary
Monogram Orthopaedics beats Treace Medical Concepts on 11 of the 19 factors compared between the two stocks.
Get Monogram Orthopaedics News Delivered to You Automatically
Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Monogram Orthopaedics Competitors List
Related Companies and Tools
This page (NASDAQ:MGRM) was last updated on 3/27/2025 by MarketBeat.com Staff
Buy MGRM Stock Free MGRM Stock Alerts